Anti-Mullerian Hormone Test Market Size & Forecast to 2032

The Anti-Mullerian Hormone Test Market is experiencing consistent expansion, driven by rising global demand for advanced reproductive diagnostics, increasing adoption of decentralized testing, and shifting regulatory conditions. Senior decision-makers are navigating a dynamic environment where technological innovation, supply chain resilience, and collaborative partnerships define competitive advantage.

Market Snapshot

From 2025 to 2026, the Anti-Mullerian Hormone Test Market increased from USD 340.21 million to USD 381.30 million. Projected to continue its 11.83% compound annual growth rate, the market is expected to reach USD 744.42 million by 2032.

Scope & Segmentation

Product Formats: Includes point-of-care solutions and self-collection kits, each optimized for specific clinical workflows and user capabilities.
Component Ecosystems: Segmented into benchtop analyzers, portable devices, as well as customized and standard assay kits.
Clinical Applications: Encompass ovarian reserve assessment, polycystic ovary syndrome diagnosis, and prediction of premature ovarian failure, informing both diagnostic positioning and evidence-based adoption.
End Users: Targeting diagnostic laboratories, fertility clinics, hospitals, and research institutes that require tailored commercial and technical support models.
Geographical Regions: Analysis covers the Americas, Europe Middle East & Africa, and Asia-Pacific, accounting for procurement behaviors, regulatory frameworks, and manufacturing localization trends.
Technological Progress: Assesses advancements in assay miniaturization, automation, enhanced sensitivity, integration with digital platforms, and interoperability across clinical and operational systems.

Key Takeaways

AMH testing now plays a foundational role in modern reproductive medicine, with clinical use extending from research laboratories to patient-facing fertility services.
Decentralization and digital transformation, including widespread adoption of portable and self-use kits, are improving access and allowing patient-centered workflows while requiring rigorous standardization of assay results.
Diagnostic suppliers are increasingly investing in vertically integrated delivery models, offering bundled instruments, reagents, and analytics to meet diverse quality and operational demands.
Multi-stakeholder partnerships—spanning fertility networks, hospitals, and research institutes—are accelerating clinical integration, generating real-world evidence and fostering cross-industry innovation.
Component sourcing strategies are adapting to shifting regulatory and geopolitical influences, with manufacturers localizing production and prioritizing regional supply chain resilience.
Dilution of procurement risk and emphasis on quality assurance are visible across segments, as end users demand reliable post-market support and agile vendor collaborations.

Tariff Impact

Recent U.S. tariff measures have reshaped AMH diagnostic supply chains and procurement processes. Import duties on essential instruments and reagents have increased operational costs, prompting suppliers to localize production, renegotiate long-term contracts, and seek regional vendor diversification. These changes have also triggered innovation in assay design, emphasizing resource availability and regulatory compatibility. As a result, manufacturers are validating new product adaptations to uphold clinical standards, even as procurement cycles grow more complex and risk averse.

Methodology & Data Sources

Analysis in this report is built on triangulation: primary interviews with laboratorians, clinical specialists, procurement officers, and product leaders; cross-referenced with clinical literature, regulatory documents, technical specifications, and practice guidelines. Data were validated through scenario analysis and expert panel review to ensure accuracy and actionable outcomes.

Why This Report Matters

Enables leaders to anticipate operational disruptions and make data-driven procurement and market entry decisions with confidence.
Provides visibility into technology trends and partnership models shaping AMH diagnostic strategy across diverse geographies and clinical domains.
Equips commercial and clinical teams to align workflows, accelerate adoption of innovative testing modalities, and maintain patient trust.

Conclusion

Combining clinical relevance, supply resilience, and evidence-driven collaboration, the Anti-Mullerian Hormone Test Market continues to evolve toward integrated, accessible, and reliable diagnostic solutions. Leaders embracing adaptability and rigorous quality controls are well-positioned for sustained progress.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Anti-Mullerian Hormone Test Market, by Product

8.1. POC Testing
8.2. Self-check Kits

9. Anti-Mullerian Hormone Test Market, by Component

9.1. Instruments
9.1.1. Benchtop Devices
9.1.2. Portable Analyzers
9.2. Reagents & Kits
9.2.1. Customized Assays
9.2.2. Standard Assays

10. Anti-Mullerian Hormone Test Market, by Applications

10.1. Ovarian Reserve Assessment
10.2. Polycystic Ovary Syndrome Diagnosis
10.3. Premature Ovarian Failure Prediction

11. Anti-Mullerian Hormone Test Market, by End User

11.1. Diagnostic Laboratories
11.2. Fertility Clinics
11.3. Hospitals
11.4. Research Institutes

12. Anti-Mullerian Hormone Test Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Anti-Mullerian Hormone Test Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Anti-Mullerian Hormone Test Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Anti-Mullerian Hormone Test Market
16. China Anti-Mullerian Hormone Test Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbexa Limited
17.6. Ansh Labs LLC
17.7. Athenese-Dx
17.8. Bio-Rad Laboratories, Inc.
17.9. Bio-Techne Corporation
17.10. bioMérieux S.A.
17.11. BioVendor - Laboratorni Medicina A.S.
17.12. Chengdu VACURE Biotechnology Co., Ltd.
17.13. CTK Biotech, Inc.
17.14. Cusabio Technology LLC
17.15. Danaher Corporation
17.16. Eagle Biosciences, Inc.
17.17. Elabscience Bionovation Inc.
17.18. Epitope Diagnostics, Inc.
17.19. F. Hoffmann-La Roche Ltd.
17.20. Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
17.21. Goldsite Diagnostics Inc.
17.22. Healthy Human Labs Limited (Vitall)
17.23. Kamiya Biomedical Company
17.24. LifeSpan BioSciences, Inc.
17.25. London Gynaecology Limited
17.26. Meridian Bioscience, Inc.
17.27. Monobind Inc.
17.28. Siemens Healthineers AG
17.29. Thermo Fisher Scientific Inc.
17.30. Tosoh Corporation
17.31. Vitrosens Biotechnology Co., Ltd.

List of Figures

FIGURE 1. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY BENCHTOP DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY BENCHTOP DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY BENCHTOP DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PORTABLE ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PORTABLE ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY CUSTOMIZED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY CUSTOMIZED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY CUSTOMIZED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STANDARD ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STANDARD ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STANDARD ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OVARIAN RESERVE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OVARIAN RESERVE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OVARIAN RESERVE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PREMATURE OVARIAN FAILURE PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PREMATURE OVARIAN FAILURE PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PREMATURE OVARIAN FAILURE PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. EUROPE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. EUROPE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 84. EUROPE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 85. EUROPE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 86. EUROPE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 87. EUROPE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 88. EUROPE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 98. AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 99. AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 100. AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 101. AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 102. AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. ASEAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASEAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 113. ASEAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 114. ASEAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 115. ASEAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 116. ASEAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 117. ASEAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. GCC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GCC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 120. GCC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 121. GCC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 122. GCC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 123. GCC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 124. GCC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. BRICS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. BRICS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 134. BRICS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 135. BRICS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 136. BRICS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 137. BRICS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 138. BRICS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. G7 ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. G7 ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 141. G7 ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 142. G7 ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 143. G7 ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 144. G7 ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 145. G7 ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. NATO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. NATO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 148. NATO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 149. NATO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 150. NATO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 151. NATO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 152. NATO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 162. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 163. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 164. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 165. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 166. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 167. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Anti-Mullerian Hormone Test market report include:

Abbexa Limited
Ansh Labs LLC
Athenese-Dx
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
bioMérieux S.A.
BioVendor – Laboratorni Medicina A.S.
Chengdu VACURE Biotechnology Co., Ltd.
CTK Biotech, Inc.
Cusabio Technology LLC
Danaher Corporation
Eagle Biosciences, Inc.
Elabscience Bionovation Inc.
Epitope Diagnostics, Inc.
F. Hoffmann-La Roche Ltd.
Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
Goldsite Diagnostics Inc.
Healthy Human Labs Limited (Vitall)
Kamiya Biomedical Company
LifeSpan BioSciences, Inc.
London Gynaecology Limited
Meridian Bioscience, Inc.
Monobind Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Tosoh Corporation
Vitrosens Biotechnology Co., Ltd.

Table Information

Report Attribute	Details
No. of Pages	189
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 381.3 Million
Forecasted Market Value ( USD ) by 2032	$ 744.42 Million
Compound Annual Growth Rate	11.8%
Regions Covered	Global
No. of Companies Mentioned	28

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3480EUR$3,939USD£3,035GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3754EUR$4,249USD£3,273GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5088EUR$5,759USD£4,437GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6157EUR$6,969USD£5,369GBP

Anti-Mullerian Hormone Test Market - Global Forecast 2026-2032

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Fertility Testing Devices Market - Global Forecast 2026-2032

Endocrine Testing Market - Global Forecast 2026-2032

Lateral Flow Assays Market by Product (Kits, Readers), Application (STI, HEP, TB, Cardiac Marker, Pregnancy, Drug Abuse, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), and Region - Global Forecast to 2030

Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Radioimmunoassay Market - Diagnostic Applications & Forecast 2025-2033

About the Anti Mullerian Hormone Test Market